# Drug Interaction Between CKD-501 and Metformin

> **NCT01005160** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 24 (estimated)

## Conditions studied

- Healthy Male Volunteers

## Interventions

- **DRUG:** Metformin
- **DRUG:** CKD-501

## Key facts

- **NCT ID:** NCT01005160
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2009-12
- **Final completion:** 2010-02
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2011-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01005160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01005160, "Drug Interaction Between CKD-501 and Metformin". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01005160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*